Sunday, May 28, 2023
Home Tags Eisai

Tag: Eisai

Eisai and Merck Announce Results of Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients with Unresectable Hepatocellular Carcinoma
Sport

Eisai and Merck Announce Results of Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients with Unresectable Hepatocellular Carcinoma

inew -
0
Eisai Presents Post-hoc Analysis Results of Eribulin Mesylate (HALAVEN) at the 2022 European Society for Medical Oncology (ESMO) Congress
Sport

Eisai Presents Post-hoc Analysis Results of Eribulin Mesylate (HALAVEN) at the 2022 European Society for Medical Oncology (ESMO) Congress

inew -
0
Eisai Inc. partners with C2N to build awareness and real-world evidence for blood-based testing
Uncategorized

Eisai Inc. partners with C2N to build awareness and real-world evidence for blood-based testing

inew -
0

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

inew news is your website for news and entertainment. We bring you the latest news in sports (MLB- NBA- NFL), economy and technology.

FOLLOW US

© Design ❤ by gh+